Patent pools organization MPEG LA, LLC said that key holders of patents for CRISPR gene editing technology have submitted patents in response to its call to participate in the creation of a global CRISPR-Cas9 Joint Licensing Platform and that patent submissions continue to be accepted.
“Among those who have agreed to participate, MPEG LA welcomes the Broad Institute of MIT and Harvard, which has submitted key CRISPR-Cas9 patents for consideration with joint owners Harvard University, the Massachusetts Institute of Technology, and The Rockefeller University,” said MPEG.
Larry Horn, CEO of MPEG LA, said: “The enthusiastic response to MPEG LA’s patent pool initiative is further evidence of the widely held view that CRISPR is too important to be left at risk of endless patent battles and splintered licensing regimes and that a pool providing one-stop licensing efficiency and predictability to scientists and businesses worldwide represents the best hope to unleash its life-enhancing potential.
“As MPEG LA’s objective is to provide worldwide access to as much CRISPR intellectual property as possible and the market will benefit from the viewpoints of all stakeholders in this voluntary ground floor opportunity to determine CRISPR’s future, the door remains open and additional patent submissions continue to be welcomed.”
Issi Rozen, chief business officer of the Broad Institute, said: “We strongly support making CRISPR technology broadly available.
“The Broad Institute already licenses CRISPR-Cas9 non-exclusively for all applications, with the exception of human therapeutics, where we have significantly limited the exclusivity.
“We look forward to working with others to ensure the widest possible access to all key CRISPR intellectual property.”